1. Home
  2. RECT vs AIDX Comparison

RECT vs AIDX Comparison

Compare RECT & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rectitude Holdings Ltd

RECT

Rectitude Holdings Ltd

HOLD

Current Price

$1.14

Market Cap

17.3M

Sector

N/A

ML Signal

HOLD

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$1.90

Market Cap

19.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RECT
AIDX
Founded
1997
N/A
Country
Singapore
United States
Employees
111
N/A
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
19.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RECT
AIDX
Price
$1.14
$1.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.8K
126.0K
Earning Date
07-24-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$1.51
52 Week High
$4.98
$14.09

Technical Indicators

Market Signals
Indicator
RECT
AIDX
Relative Strength Index (RSI) 41.03 18.01
Support Level $1.04 $1.51
Resistance Level $1.30 $2.08
Average True Range (ATR) 0.10 0.21
MACD 0.01 0.26
Stochastic Oscillator 50.07 67.75

Price Performance

Historical Comparison
RECT
AIDX

About RECT Rectitude Holdings Ltd

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: